Literature DB >> 11788550

Life and death in the gut: more killing, less Crohn's.

A Sturm1, C Fiocchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11788550      PMCID： PMC1773097          DOI： 10.1136/gut.50.2.148

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  16 in total

1.  Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance.

Authors:  K Ina; J Itoh; K Fukushima; K Kusugami; T Yamaguchi; K Kyokane; A Imada; D G Binion; A Musso; G A West; G M Dobrea; T S McCormick; E G Lapetina; A D Levine; C A Ottaway; C Fiocchi
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

Review 2.  Tumor necrosis factor: biology and therapeutic inhibitors.

Authors:  K A Papadakis; S R Targan
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

Review 3.  T cell death and memory.

Authors:  J Sprent; D F Tough
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

Review 4.  Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

Authors:  M Feldmann; R N Maini
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.

Authors:  R Atreya; J Mudter; S Finotto; J Müllberg; T Jostock; S Wirtz; M Schütz; B Bartsch; M Holtmann; C Becker; D Strand; J Czaja; J F Schlaak; H A Lehr; F Autschbach; G Schürmann; N Nishimoto; K Yoshizaki; H Ito; T Kishimoto; P R Galle; S Rose-John; M F Neurath
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

6.  Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease.

Authors:  J Itoh; C de La Motte; S A Strong; A D Levine; C Fiocchi
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

7.  Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.

Authors:  I J Fuss; T Marth; M F Neurath; G R Pearlstein; A Jain; W Strober
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

8.  Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

Authors:  B E Sands; W J Tremaine; W J Sandborn; P J Rutgeerts; S B Hanauer; L Mayer; S R Targan; D K Podolsky
Journal:  Inflamm Bowel Dis       Date:  2001-05       Impact factor: 5.325

9.  Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.

Authors:  F Cornillie; D Shealy; G D'Haens; K Geboes; G Van Assche; J Ceuppens; C Wagner; T Schaible; S E Plevy; S R Targan; P Rutgeerts
Journal:  Aliment Pharmacol Ther       Date:  2001-04       Impact factor: 8.171

10.  Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7).

Authors:  B M Wittig; B Johansson; M Zöller; C Schwärzler; U Günthert
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307
View more
  2 in total

1.  Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease.

Authors:  A Di Sabatino; R Ciccocioppo; B Cinque; D Millimaggi; R Morera; L Ricevuti; M G Cifone; G R Corazza
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

2.  Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase.

Authors:  Sandra Angulo; Albert Morales; Silvio Danese; Laura Llacuna; Maria Carme Masamunt; Nicole Pultz; Maria Grazia Cifone; Claudio De Simone; Salvadora Delgado; Jordi Vila; Julián Panés; Curtis Donskey; Jose C Fernández-Checa; Claudio Fiocchi; Miquel Sans
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.